Chronic kidney disease as cause of cardiovascular morbidity and mortality
- PMID: 15814534
- DOI: 10.1093/ndt/gfh813
Chronic kidney disease as cause of cardiovascular morbidity and mortality
Abstract
To make an evidence-based evaluation of the relationship between kidney failure and cardiovascular risk, we reviewed the literature obtained from a PubMed search using pre-defined keywords related to both conditions and covering 18 years (1986 until end 2003). Eighty-five publications, covering 552 258 subjects, are summarized. All but three studies support a link between kidney dysfunction and cardiovascular risk. More importantly, the association is observed very early during the evolution of renal failure: an accelerated cardiovascular risk appears at varying glomerular filtration rate (GFR) cut-off values, which were >/=60 ml/min in at least 20 studies. Many studies lacked a clear definition of cardiovascular disease and/or used a single determination of serum creatinine or GFR as an index of kidney function, which is not necessarily corresponding to well-defined chronic kidney disease. In six studies, however, chronic kidney dysfunction and cardiovascular disease were well defined and the results of these confirm the impact of kidney dysfunction. It is concluded that there is an undeniable link between kidney dysfunction and cardiovascular risk and that the presence of even subtle kidney dysfunction should be considered as one of the conditions necessitating intensive prevention of this cardiovascular risk.
Similar articles
-
[Advances in detection, evaluation and management of chronic kidney disease].Laeknabladid. 2007 Mar;93(3):201-7. Laeknabladid. 2007. PMID: 17341799 Review. Icelandic.
-
The glomerular filtration rate in an apparently healthy population and its relation with cardiovascular mortality during 10 years.Eur Heart J. 2007 Feb;28(4):478-83. doi: 10.1093/eurheartj/ehl455. Epub 2007 Jan 12. Eur Heart J. 2007. PMID: 17223665
-
Impact of kidney disease and blood pressure on the development of cardiovascular disease: an overview from the Japan Arteriosclerosis Longitudinal Study.Circulation. 2008 Dec 16;118(25):2694-701. doi: 10.1161/CIRCULATIONAHA.108.792903. Circulation. 2008. PMID: 19106392
-
Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population.Am J Epidemiol. 2008 May 15;167(10):1226-34. doi: 10.1093/aje/kwn033. Epub 2008 Apr 2. Am J Epidemiol. 2008. PMID: 18385206
-
[Glomerular filtration rate and cardiovascular risk: prognostic and therapeutic implications].G Ital Nefrol. 2008 Jan-Feb;25(1):21-31. G Ital Nefrol. 2008. PMID: 18264915 Review. Italian.
Cited by
-
Management of CKD-MBD in non-dialysis patients under regular nephrology care: a prospective multicenter study.J Nephrol. 2016 Feb;29(1):71-8. doi: 10.1007/s40620-015-0202-4. Epub 2015 May 19. J Nephrol. 2016. PMID: 25986389
-
Coronary calcification in patients with chronic kidney disease and coronary artery disease.Clin J Am Soc Nephrol. 2009 Dec;4(12):1892-900. doi: 10.2215/CJN.04320709. Epub 2009 Oct 15. Clin J Am Soc Nephrol. 2009. PMID: 19833908 Free PMC article.
-
Ergocalciferol improves endothelial vasodilatory and vasoconstrictor function in an in vivo model of mild uraemia.Biosci Rep. 2019 Dec 20;39(12):BSR20190711. doi: 10.1042/BSR20190711. Biosci Rep. 2019. PMID: 31789348 Free PMC article.
-
Uraemic toxins and cardiovascular disease: in vitro research versus clinical outcome studies.NDT Plus. 2008 Feb;1(1):2-10. doi: 10.1093/ndtplus/sfm024. Epub 2007 Dec 19. NDT Plus. 2008. PMID: 30792775 Free PMC article. No abstract available.
-
Protein-bound uremic toxins: new insight from clinical studies.Toxins (Basel). 2011 Jul;3(7):911-9. doi: 10.3390/toxins3070911. Epub 2011 Jul 20. Toxins (Basel). 2011. PMID: 22069747 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical